Persistent Extensive Microcalcifications After Neoadjuvant Chemotherapy: Benign or Malignant?

Neoadjuvant chemotherapy is increasingly used for breast cancer due to its several benefits. Assessment of the response to neoadjuvant chemotherapy plays a key role in the management of the disease. Although magnetic resonance imaging is the most accurate method, evaluation of the response to neoadjuvant chemotherapy may be challenging especially in the presence of residual microcalcifications. The presence of residual microcalcifications may not always suggest the residual viable tumor. In this case, a 48-year-old patient with breast cancer who had persistent extensive microcalcifications after neoadjuvant chemotherapy is presented. Magnetic resonance imaging demonstrated a complete response with the absence of any residual enhancement. Final histopathological results after breast-conserving surgery revealed pathological complete response which is consistent with magnetic resonance imaging and inconsistent with mammography findings. Mammography images showed residual malignant-type microcalcification after surgery, although most of them were excised. However, microcalcifications haven’t progressed and recurrent cancer hasn’t been observed on MRI and mammography images during the 10- year follow-up.

PDF

___

[1] Fowler AM, Mankoff DA, Joe BN. Imaging Neoadjuvant Therapy Response in Breast Cancer. Radiology 2017; 285: 358-375.
[2] Taydas O, Durhan G, Akpinar MG, Demirkazik FB. Comparison of MRI and US in Tumor Size Evaluation of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Eur J Breast Health 2019; 15: 119-124.
[3] Croshaw R, Shapiro-Wright H, Svensson E et al. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann Surg Oncol 2011; 18: 3160-3163.
[4] Nguyen TT, Hoskin TL, Day CN et al. Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol 2018; 25: 2596-2602.
[5] von Minckwitz G, Untch M, Blohmer JU et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012; 30: 1796-1804.
[6] Feliciano Y, Mamtani A, Morrow M et al. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised? Ann Surg Oncol 2017; 24: 1492-1498.
[7] Shin GW, Park YM, Yoon HK et al. Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer. J Breast Cancer 2016; 19: 459- 464.
[8] Li JJ, Chen C, Gu Y et al. The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation. PLoS One 2014; 9: e88853.